Mahim Jain, MD, PhD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Travere Therapeutics
    Topic:
    Insurance Database Analysis
    Date added:
    07/15/2024
    Date updated:
    10/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Amgen
    Topic:
    Clinical trial site investigator
    Date added:
    09/09/2024
    Date updated:
    10/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Ultragenyx
    Topic:
    Clinical trial site investigator
    Date added:
    09/09/2024
    Date updated:
    10/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Med-Life
    Topic:
    Clinical trial site investigator
    Date added:
    10/28/2026
    Date updated:
    10/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Angitia
    Topic:
    Clinical trial site investigator
    Date added:
    10/28/2026
    Date updated:
    10/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Biomarin
    Topic:
    Clinical trial site investigator
    Date added:
    10/28/2026
    Date updated:
    10/28/2026
Return to From Prenatal Diagnosis to Delivery and Beyond: Optimizing Outcomes for Rare Genetic Musculoskeletal Disorders